Literature DB >> 17161155

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

W T Creasman, F Odicino, P Maisonneuve, M A Quinn, U Beller, J L Benedet, A P M Heintz, H Y S Ngan, S Pecorelli.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17161155     DOI： 10.1016/S0020-7292(06)60031-3

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  230 in total

1.  Endometrial cancer.

Authors:  Kimberly K Leslie; Kristina W Thiel; Michael J Goodheart; Koen De Geest; Yichen Jia; Shujie Yang
Journal:  Obstet Gynecol Clin North Am       Date:  2012-06       Impact factor: 2.844

2.  Fertility-Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot Study.

Authors:  Paolo Casadio; Francesca Guasina; Roberto Paradisi; Concetta Leggieri; Giacomo Caprara; Renato Seracchioli
Journal:  Oncologist       Date:  2018-01-09

3.  Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.

Authors:  A Stiekema; Car Lok; C M Korse; W J van Driel; V van der Noort; G G Kenter; K K Van de Vijver
Journal:  Virchows Arch       Date:  2017-04-11       Impact factor: 4.064

Review 4.  Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

Authors:  Mi-La Kim; Seok Ju Seong
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

Review 5.  Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.

Authors:  Jonathan D Black; Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Womens Health (Lond)       Date:  2014-01

6.  Cardiovascular disease mortality among women with endometrial cancer in the Iowa Women's Health Study.

Authors:  Ashley S Felix; Cindy K Blair; Amy Lehman; Julie K Bower; Subha V Raman; DeAnn Lazovich; David E Cohn; Anna E Prizment
Journal:  Cancer Causes Control       Date:  2017-09-01       Impact factor: 2.506

7.  Sexual Function, Sexual Activity and Quality of Life in Women with Ovarian and Endometrial Cancer.

Authors:  P Harter; I Schrof; L M Karl; R Hils; V Kullmann; A Traut; H Scheller; A du Bois
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-05       Impact factor: 2.915

8.  How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study.

Authors:  Sokbom Kang; Jong-Min Lee; Jae-Kwan Lee; Jae Weon Kim; Chi-Heum Cho; Seok-Mo Kim; Sang-Yoon Park; Chan-Yong Park; Ki-Tae Kim
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

9.  Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.

Authors:  Jung Mi Byun; Su Sun Kim; Ki Tae Kim; Mi Seon Kang; Dae Hoon Jeong; Dae Sim Lee; Eun Jung Jung; Young Nam Kim; Jin Han; In Sung Song; Kyoun Bok Lee; Moon Su Sung
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

Review 10.  [Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background].

Authors:  L-C Horn; K Schierle; D Schmidt; U Ulrich; A Liebmann; C Wittekind
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.